The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment with Esomeprazole 20 mg qd to Placebo qd in Patients with Heartburn and Sleep Disturbances Associated with Gastroesophageal Reflux Disease (GERD)
- collapse An open label, multicentre study of Nexium (esomeprazole) 40 mg once daily in subjects with symptoms of Gastroesophageal Reflux Disease (GORD) after treatment with a full dose of Proton Pump Inhibitor (PPI) - NEON
- collapse A cross-sectional, Canadian, multi-centre study of symptom burden and clinical management in subjects with Gastroesophageal Reflux Disease (GERD) RANGE: Retrospective ANalysis of GErd
- collapse Evaluation of the efficacy of three strategies of long-term management of symptoms of gastroesophageal reflux in general medicine: a multicentre, randomised, open label study conducted in parallel groups.
- collapse SYMPATHY (Symptom Adapted Therapy) A randomised, open, parallel-group, multi-national, multi-centre, phase IV study to evaluate the efficacy of three different subject management strategies with and without esomeprazole 20 mg during a 3 months maintenance phase following an initial 4-weeks acute treatment phase in subjects with symptoms thought to be GERD related
- collapse An Open-Label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium I.V. (esomeprazole sodium) 40 mg BID for up to 72 hours
- collapse A Randomized, Open-Label, Comparative 3-way Crossover Study of 24-hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40 mg, Lansoprazole 30 mg, and Pantoprazole 40 mg at Steady State in Hispanic Patients with Symptomatic GERD
- collapse A study to assess the effectiveness of Esomeprazole 40 mg once daily patients with continuing Gastroesophageal Reflux Disease (GORD) following treatment with a previous full dose Proton Pump Inhibitor An 8 week, open label, multicentre study. (RESPONSE Study)
- collapse Nexium in patients submitted to a gastric by-pass surgery
- collapse Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response
